{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-120197","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2025-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.812067+00:00","generated_at":"2026-05-16T13:40:20.946073+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Citius Oncology raises $18M in registered direct & private placement; funds LYMPHIR launch","bullets":["Gross proceeds ~$18M from sale of 1,284,404 shares at $1.09 + 15,229,358 pre-funded warrants at $1.0899 per unit.","Net proceeds ~$15.2M after fees; H.C. Wainwright acted as placement agent (7% fee).","Concurrent private placement includes warrants exercisable at $1.09 upon stockholder approval, 5-year term.","Existing warrants for 11,961,040 shares amended to $1.09 exercise price and exercisable after stockholder approval.","Citius Pharma promissory note maturity amended to require $50M of gross proceeds raised before maturity."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-120197","json":"https://secwatch.observer/filing/0001213900-25-120197.json","markdown":"https://secwatch.observer/filing/0001213900-25-120197.md","text":"https://secwatch.observer/filing/0001213900-25-120197.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025120197/0001213900-25-120197-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025120197/ea0269093-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:40:20.946073+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}